ORIGINAL RESEARCH article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1612623
This article is part of the Research TopicUnraveling the Immune Microenvironment in Cancer Patients via Transcriptome and Single-Cell Sequencing during Immunotherapy CombinationsView all 5 articles
Integrated Multi-omics Analysis of Single-cell and Spatial Transcriptomics Reveals Distinct HPV-associated Immune Microenvironment Features and Prognostic Signatures in Cervical Cancer
Provisionally accepted- 1Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China
- 2National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
- 3Guangdong Provincial People's Hospital, Guangzhou, Guangdong Province, China
- 4Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Cervical cancer (CC) is a highly heterogeneous malignancy primarily driven by persistent infection with high-risk human papillomavirus (HPV). However, comprehensive analyses of heterogeneity in the immune microenvironment, particularly its spatial heterogeneity, between HPV-positive and HPV-negative CC remain limited, despite their critical clinical significance.We performed single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) sequencing on collected cervical cancer samples, integrating scRNA-seq, ST, and bulk RNA-seq to analyze distinct cell subtypes and characterize their spatial distribution. Multiplex immunofluorescence analysis was further utilized to validate HPV status-specific expression patterns. Cox regression and LASSO regression analyses were used to identify the prognostic signature on the TCGA dataset.Through integrative analysis, we found that HPV-positive samples demonstrated elevated proportions of CD4 + T cells and cDC2s, whereas HPV-negative samples exhibited increased CD8 + T cell infiltration. In HPV-positive CC, epithelial cells acted as primary regulators of cDC2s via the ANXA1-FPR1/3 pathway, with cDC2s subsequently modulating CD4 + T cells and interferon-related CD8 + T cell subtypes. In contrast, HPV-negative CC featured epithelial cells predominantly influencing monocytes and macrophages, which then interacted with CD8 + T cells.Notably, the MDK-LRP1 ligand-receptor interaction emerged as a potential key mechanism for recruiting immunosuppressive cells into CC tumors, fostering an immunosuppressive microenvironment. Further, we constructed a risk score model based on an epithelial cell-related signature (ERS), which was significantly associated with patient survival. Noteworthy variations were observed in immune cell infiltration and immune microenvironment among distinct risk groups.Based on integrated multi-omics data, we precisely delineated the spatial transcriptional features of the tumor microenvironment in CC with different HPV statuses, including identifying distinct CD8 + T cell states and cell-cell communication.In addition, we developed an ERS closely associated with the immune environment and prognosis of CC. These results increase our understanding of the molecular mechanisms of cervical cancer under different HPV statuses and provide assistance for the precise treatment of cervical cancer.
Keywords: cervical cancer, HPV, single-cell sequencing, Spatial transcriptomics, Tumor Microenvironment, Prognostic factor
Received: 25 Apr 2025; Accepted: 11 Aug 2025.
Copyright: © 2025 Su, Tian, Li, Yu, Gong, Chen, Jianan, Yang, Zhang, Zhang and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shanshan Yang, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.